Company
About InCarda
Our Team
Board of Directors
Investors
Advisory Board
Careers
Our Pipeline
Pipeline Overview
Orally Inhaled Flecainide for PAF
About Atrial Fibrillation
News
Contact
Company
About InCarda
Our Team
Board of Directors
Investors
Advisory Board
Careers
Our Pipeline
Pipeline Overview
Orally Inhaled Flecainide for PAF
About Atrial Fibrillation
News
Contact
Our Team
InCarda is led by a seasoned team with highly complementary expertise.
Myles D. Greenberg, MD, MBA
President & Chief Executive Officer
Carlos Schuler, Ph.D.
Chief Technology Officer & Co-Founder
Carol Manchester, CPA
Chief Financial Officer*
Luiz Belardinelli, M.D.
Chief Medical Officer
Narsi Rangachari, M. Pharm.
Co-Founder & COO*
Kipp Hansen
Director, Quality Assurance
Meisa Propst
Vice President,
Clinical Operations
Priscilla Propst
Clinical Trial Assistant
Debra S. Echt, M.D.
Consultant
Frances Jolivette
Consultant
Samantha Miller
Consultant
Anna Popovici
Consultant
Leo Santana
Consultant
Consultant
*Consulting
For more information about InCarda:
Contact Us